Abstract | BACKGROUND: METHODS: Eight human tumor cell lines, including HepG2, HuH7, SMMC-7721, HeLa, HCT116, MCF-7, K562, and Jurkat were cultured. After culturing the platelet supernatant of days 0, 3, 5, and 7 with tumor cells, counting kit 8 (CCK-8), scratch assay, and propidium iodide (PI) were used to evaluate cell proliferation, migration, and cell cycle, respectively. Metabolomics analysis was performed to confirm whether differential metabolites produced during platelet storage are involved in the cancer pathway. RESULTS: Platelet supernatants inhibit tumor cell proliferation by blocking the cell cycle at the G0/G1 phase, and their inhibitory effect increases with storage time. However, platelets promote tumor cells to form cytoskeletal connections, thereby promoting migration. Besides, metabonomics analysis of platelet supernatants during different storage periods reveals that upregulated differential metabolites are involved in cancer-related pathways. CONCLUSION: The role of platelets in tumor cells is two-sided, that is, they inhibit proliferation while promoting migration. Therefore, additional in-depth studies on the appropriate timing of platelet transfusion are necessary.
|
Authors | Fei Pu, Xiaofei Li, Shufang Wang, Yuanshuai Huang, Deqing Wang |
Journal | Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
(Transfus Apher Sci)
Vol. 60
Issue 2
Pg. 103042
(Apr 2021)
ISSN: 1473-0502 [Print] England |
PMID | 33376060
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Topics |
- Adult
- Blood Platelets
(metabolism)
- Blood Preservation
(methods)
- Cell Line, Tumor
- Cell Proliferation
- Female
- Humans
- Male
- Middle Aged
|